Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

American Society for Clinical Pathology Joins Forces with Clinical Lab 2.0 to Host Fourth Annual Clinical Lab 2.0 Workshop, Oct. 26-27


News Image

“Pathologists and medical laboratory scientists should seek to play a major role in driving this revolution in healthcare,” said James Crawford, MD, PhD. “ASCP is an organization that has played a significant leadership role in healthcare reform.”

The COVID-19 pandemic has put the laboratory’s critical role in health care in the spotlight. The clinical laboratory is at the epicenter of revolutionary change sweeping across the entire healthcare field, and laboratories must be prepared to embrace these changes in order to survive and thrive.

That is the focus of the virtual 4th Annual Clinical Lab 2.0 Workshop that the American Society for Clinical Pathology (ASCP) is co-sponsoring with Clinical Lab 2.0, Oct. 26-27. In light of this year’s pandemic, the workshop is being held online. An initiative of the Project Santa Fe Foundation (PSFF), Clinical Lab 2.0 is a business model that strives to ensure the clinical laboratory is prepared for the future, in light of the many changes taking place in health care.

“Health care is moving rapidly from a volume-based approach to a value-based approach, and these changes are coming into play very quickly because of technology and other innovations, along with changes in reimbursements, education, and the workforce shortfall,” said ASCP CEO E. Blair Holladay, PhD, MASCP, SCT(ASCP)CM.

“ASCP is very pleased to partner with Clinical Lab 2.0 on this upcoming workshop and on future initiatives,” he added. “The clinical laboratory needs to be prepared and Clinical Lab 2.0 has been at the forefront in helping our field to prepare.”

“The lab’s potential impact doesn’t end when we release a result; rather, that’s where it begins,” said Khosrow R. Shotorbani, MBA, MT(ASCP) President, Executive Director, Project Santa Fe Foundation Founder, and CEO, Lab 2.0 Strategic Services, LLC. “We look forward to the synergies that our collaboration with ASCP advancing the Clinical Lab 2.0 Movement! ”

The workshop will facilitate real-time, peer review dialogue on the Clinical Lab 2.0 model for COVID-19 response, its ability to create new norms to solve new problems, and its vital relationship to public and population health. The curriculum has been developed by Project Santa Fe Foundation, whose leaders hail from organizations that are driving the movement from test-volume to lab-value, including Northwell Health, Geisinger Health Systems, Henry Ford Health System, TriCore Reference Laboratories, Intermountain Healthcare, University of Vermont Medical Center, Mayo Clinical Laboratories, Kaiser Permanente and North Shore University Health System.

“Pathologists and medical laboratory scientists should seek to play a major role in driving this revolution in healthcare,” said James Crawford, MD, PhD, Chair of the Board, PSFF, and Senior Vice President for Laboratory Services at Northwell Health. “ASCP is an organization that has played a significant leadership role in healthcare reform, addressing areas such as laboratory data interoperability with electronic health records, meeting meaningful use requirements for laboratory data, articulating the role of pathology in accountable care, including reducing unnecessary utilization of laboratory tests, and addressing the workforce shortage.”

For 2020, the Clinical Lab 2.0 Workshop $1500 registration fee will be waived for members of the lab community, making the event free of charge for laboratory institutions. To register, visit: https://projectsantafefoundation.regfox.com/clinical-lab-20-workshop.

About ASCP

Founded in 1922 in Chicago, ASCP is the world’s largest professional membership organization for pathologists and laboratory professionals. ASCP provides excellence in education, certification, and advocacy on behalf of patients, anatomic and clinical pathologists, and medical laboratory professionals. To learn more, visit http://www.ascp.org. Follow us on Twitter at http://www.twitter.com/ascp_chicago and connect with us on Facebook at http://www.facebook.com/ASCP.Chicago.

About Clinical Lab 2.0

Clinical Lab 2.0 is a Project Santa Fe Foundation initiative. It was established to provide thought leadership and help develop the evidence base for the valuation of clinical laboratory services in the next era of global healthcare. The participants in Project Santa Fe represent major organizations in clinical diagnostics, uniting to operationalize laboratory-driven innovations and test their valuation in diverse global marketplaces. For more information, please visit Clinical Lab 2.0 at http://www.cl2lab.org/

###

Share article on social media or email:



MMA Champion The Mane Event (™) Elias Theodorou Brings Mixed Martial Arts Back to Fans This Fall


MMA Champion The Mane Event (™) Elias Theodorou Brings Mixed Martial Arts Back to Fans This Fall

This fall, Elias will look to make professional sports history in his next fight, as the first sanctioned cannabis athlete in a jurisdiction (TBA) that recognizes his medical cannabis rights.

Elias Theodorou will be returning to the cage as both fighter and co-promoter with Rise FC this fall in Canada’s first contact sports event since competition was suspended due to COVID19 in the Spring. The ‘Mane Event®’ has joined forces with ImagineBC, a revolutionary new media company that promotes a safe and equitable digital platform to stream his next bout.

Elias is a UFC veteran and the first-ever Canadian winner of the reality show/tournament, The Ultimate Fighter. He is also dedicated to ‘Fighting the Stigma’ of medical cannabis in sports.

Theodorou is the first professional athlete and MMA fighter in the world to receive a therapeutic use exemption (TUE) for medical cannabis in competition, which was granted in February by the British Columbia Athletic Commission. This historic ruling sets a precedent not only for Elias but all other MMA athletes and boxers in BC who may now apply for the same TUE where medically appropriate. This fall, Elias will look to make professional sports history in his next fight, as the first sanctioned cannabis athlete in a jurisdiction (TBA) that recognizes his medical cannabis rights.

Elias is pleased to announce his new partnership with ImagineBC, which will stream the event exclusively on their digital platform: “I collaborated with ImagineBC to bring this unique event to life because we share a vision of a more equitable future for all athletes, creators, and personalities. It’s important to me to provide a safe, accessible and inclusive platform for my audience, and ImagineBC is the best possible partner to support this vision.” says Theodorou. “Imagine BC’s platform is levelling the playing field for advocates like me. The ability to securely age-gate my content for a 19+ audience allows me to work within the current Canadian marketing regulations in a compliant way, while still being able to provide authentic content to my loyal fans.”

“As a mission-driven company, our commitment to ensuring that creative professionals, such as Elias, are fairly compensated and recognized for their work is foundational to our business model,” explains Erik Rind, CEO and Founder of ImagineBC. “Finding alignment with Elias was natural as not only does he understand the type of transformation we’re working toward, but he is committed to helping change the way data is valued.”

The event will be taking place this fall and streamed exclusively on Imagine BC’s new digital platform. It will also include access to Elias’ premiere content. The fight is supported by several plant-based sponsors. Fans can learn more about Elias’ channel and fight streaming information at http://www.imaginebc.net/elias-theodorou.

About Elias Theodorou

Elias, “The Spartan” Theodorou, is a top-ranked middleweight fighter who amassed an impressive 8-3 record during his time in the UFC. Elias is committed to fighting the stigma of medical cannabis in athletics. In January 2020, he became the first professional athlete to receive a Therapeutic Use Exemption (TUE) for medical cannabis, the first in combat sports or professional sports. Elias has transcended the stereotypes of a fighter by employing his advertising degree and corporate experience in the development, creation, and production of personal and corporate brands, including The Mane Event™, The Ring Boy™ and Weedbae™ When Elias is not busy training or competing, he’s working on several films and various TV projects. Elias is committed to using his growing platform to expand his reach beyond MMA and to fight for acceptance of medical cannabis in professional sports.

Follow Elias on Facebook, Twitter, and Instagram.

About ImagineBC

ImagineBC is a next-generation media company shaping a new landscape for a better world, empowering both content creators and consumers alike to unlock monetary value. By building an open, safe and equitable digital community, ImagineBC is championing a new path that allows everyone to participate in the economics of their data and thereby ensuring that the benefits are enjoyed by all, not just a few. ImagineBC is available in both the United States and Canada iOS, Android, and web portal. Follow ImagineBC on Twitter, LinkedIn, and Instagram.

To learn more about ImagineBC, visit ImagineBC.net

Media Contacts:

Elias Theodorou

Jessica Moran

Founder

JESSCO

jess@jessmco.com

519-494-5379

Share article on social media or email:



Aesthetics Biomedical® Inc. Announces Vivace® RF Microneedling Partnership With SkinCeuticals C E Ferulic For Newest In-Office Treatment Experience


Vivace Microneedling

Vivace Microneedling

From an industry perspective, this relationship is disruptive, with ABM aligning with a brand that’s a longtime industry mainstay like SkinCeuticals. We’ve forged our own path to bring the best skincare treatments, products and business practices to a wider audience.

Aesthetics Biomedical® Inc., a leader in novel aesthetic products and devices, and SkinCeuticals, a leader in advanced skincare technology, announce the launch of the collaboration that combines Vivace® Microneedle RF with a post-treatment protocol featuring SkinCeuticals C E Ferulic for enhanced patient experience with minimally-invasive skin rejuvenation treatments.

To give patients visibly brighter, more radiant skin, Aesthetics Biomedical’s industry leading, FDA-cleared, radiofrequency microneedling technology, Vivace® has partnered with the #1 professional skincare brand in the U.S., SkinCeuticals. A minimally-invasive treatment, Vivace® stimulates the natural production of collagen and has been shown by physicians to be effective in alleviating facial wrinkles, fine lines, improving skin texture, tightening and toning the face and neck for an overall glow. Uniquely designed for an incomparable, comfortable patient experience, only Vivace® boasts a precision robotic motor that brings maximum results with minimal discomfort compared to other devices.

Sheldon Larson, Chief Marketing Officer at Aesthetics Biomedical® who spearheaded this partnership initiative states “As two leading skincare powerhouses, partnering together allows us to really make an impact on overall skin health. Both physicians and patients will see the benefits it brings to their Vivace Experience® by extending the post-treatment care with SkinCeuticals hero product, C E Ferulic.” Larson continues. “From an industry perspective, this relationship is disruptive, with ABM aligning with a brand that’s a longtime industry mainstay like SkinCeuticals. We’ve forged our own path to bring the best skincare treatments, products and business practices to a wider audience for the ultimate benefit of our physicians.”

For one day following patients’ Vivace® RF Microneedling treatment, the skincare protocol for patients is now complemented with the use of SkinCeuticals C E Ferulic, the iconic daytime Vitamin C serum, proven to deliver advanced environmental protection and visible anti-aging results. C E Ferulic works to further enhance the Vivace Experience®, 24 hours post treatment and provides astonishing results after just one session. SkinCeuticals antioxidant formulations are the gold standard and results have shown a 44% improvement in skin radiance, 36% improvement in the appearance of wrinkles and 37% increase in skin firmness.

MaryAnn Guerra, CEO & President of Aesthetics Biomedical® adds, “Aesthetics Biomedical has always advocated for the best patient experience. That is why we created the Vivace Experience® to ensure not only a great treatment but to follow-through with that positive experience post treatment. The right treatment combined with the right products to ensure the best outcomes. It doesn’t get better than Vivace® x SkinCeuticals.”

On the partnership, SkinCeuticals General Manager, Christina Fair notes, “SkinCeuticals is thrilled to collaborate with Aesthetics Biomedical® to create this unique, innovative treatment that provides rejuvenation benefits and antioxidant protection.” She continues, “This collaboration aligns with our goals to provide optimal patient outcomes through the synergy of SkinCeuticals scientifically-backed skincare and professional treatments.”

Vivace Experience® featuring SkinCeuticals C E Ferulic can be found through skincare physicians nationwide; for locations and pricing visit VivaceExperience.com or SkinCeuticals.com. Follow along on social media or share your experience using #VivaCEFerulic and tagging @VivaceExperience & @SkinCeuticals.

ABOUT AESTHETICS BIOMEDICAL

Aesthetics Biomedical, Inc., headquartered in Phoenix, Ariz., is committed to the development and distribution of novel aesthetic devices, products, and services in the global market. Aesthetics Biomedical’s innovation center is a leader in breakthrough technologies and combination therapies for its clients, physician network and the aesthetic arena, creating novel patient treatment experiences that benefit from ongoing research, approved clinical indications for use, as well as a personalized approach designed for consumer benefit. Visit AestheticsBiomedical.com or VivaceExperience.com.

CONTACTS:

Press Contact: Courtney Frappier: (214) 505-5173 / CFrappier@aestheticsbiomed.com

Marketing Contact: Sheldon Larson: (602) 682-6423 / Sheldon@aestheticsbiomed.com

Share article on social media or email:

What It Is, How to Analyze It, Make It Work for You Webinar Oct. 15, 2020


WCG FDAnews

WCG FDAnews

Reliability for Medical Devices:

What It Is, How to Analyze It, Make It Work for You

An FDAnews Webinar

Thursday, Oct. 15, 2020, 1:30 p.m.-3:00 p.m. EDT

https://www.fdanews.com/reliabilitymd

Take medical devices to the next level of reliability and achieve the best in product quality.

Join us on Oct. 15 for the Reliability for Medical Devices webinar where Dan O’Leary, President of Ombu Enterprises, will share how to distinguish between reliability and safety. While there’s much overlap, they require different tools and techniques for analysis. He’ll use examples to explain how to implement tools and methods for producing reliable devices, including:

  • An introduction to the concepts of reliability
  • An introduction to the concepts of maintainability
  • Availability as the combination of reliability and maintainability
  • Distinguishing between safety and reliability
  • Methods and tools for reliability
  • The relationship between reliability and warranty cost (early failures and how they can significantly affect warranty claims)


Reliability is often not well understood, despite it being vital to devicemakers. Bring medical device to the next level through reliability tools and techniques.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Reliability for Medical Devices:

What It Is, How to Analyze It, Make It Work for You

An FDAnews Webinar

Thursday, Oct. 15, 2020, 1:30 p.m.-3:00 p.m. EDT

https://www.fdanews.com/reliabilitymd

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/reliabilitymd

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

Jim Ellis Automotive Group Raises $35,000 for Atlanta Beats Covid


News Image

“Our hope with this donation is that together, we can really support Atlanta Beats Covid with their efforts to purchase more materials so they can continue making supplies that our community, particularly our teachers and educators, desperately need.”

Jim Ellis Automotive Group held its group-wide Labor Day Sales Event from August 31 to September 7, where a portion of the proceeds from all new and pre-owned vehicles sold was raised for Atlanta Beats Covid (ABC). With all 18 Jim Ellis family-owned and operated dealerships participating in the holiday promotion, the company announced a collective donation of $35,000 to ABC. The donation supports ABC’s mission of providing personal protective equipment (PPE) to teachers and special needs students in Atlanta communities.

Following the donation presentation on September 9th, ABC has manufactured and distributed 19,268 PPE items to Centennial High School, River Eves Elementary, Esther Jackson Elementary, Woodstock Elementary, Mountain Road Elementary, Chamblee Middle School, and Teasley Middle School. Categories and quantity of items donated to the schools are as follows: 3,870 face shields, 3,072 bottles of hand sanitizer, 10,634 masks and 1,692 sanitizing wipes.

“We are humbled to make this donation to Atlanta Beats Covid and thank them for their fabulous work on helping those in our community have face shields and face masks that will help keep them safe during this challenging time,” said Jimmy Ellis, president of Jim Ellis Automotive Group. “Our hope with this donation is that together, we can really support Atlanta Beats Covid with their efforts to purchase more materials so they can continue making supplies that our community, particularly our teachers and educators, desperately need.”

It is not uncommon that schools or districts do not provide educators or students with face shields, masks and other items deemed essential for a potentially vulnerable environment. Along with that, educators and staff may encounter difficulties getting their hands on PPE for themselves due to a nationwide shortage and shipping delays.

ABC says the Jim Ellis Automotive Group donation will continue to help support ABC with fulfilling the PPE requests from principals and administrators.

About Atlanta Beats Covid

We are an ad-hoc group of volunteer makers, engineers, fabricators, seamsters, and other Southeast industry experts that are working to provide our hard-working healthcare providers and other vital members of our community with the necessary PPE that they need to stay safe while battling COVID-19. For more information about ABC, request PPE, or to donate, please visit our website: https://atlantabeatscovid.com/

About Jim Ellis Automotive Group

Jim Ellis Automotive Group has been serving the Atlanta area since 1971, starting with Volkswagen as the flagship brand. The group has expanded to 14 brands and 18 dealerships covering Atlanta, Buford, Kennesaw, Marietta and McDonough. Visit them online at http://www.jimellis.com.

Share article on social media or email:

Colorado State University Global Launches Fully Online Master of Science in Nursing Program


Logo

“As the healthcare profession continues to experience extraordinary demand, there is an increased need for trained and qualified nurse leaders,” said CSU Global Provost and Vice President of Strategic Development, Dr. Karen Ferguson.

Colorado State University Global (CSU Global)—the premier provider of high-quality, career-relevant, and affordable education—is proud to announce its Master’s of Science in Nursing (MSN), a fully online degree that equips students with the expertise and practical skills needed to advance in their healthcare careers.

Specifically designed for nurses who are looking to advance into leadership roles, the MSN offering provides a flexible degree option that accommodates non-traditional and professional schedules. The curriculum is aligned with the American Association of Colleges of Nursing’s CCNE Standards and Professional Nursing Guidelines and will address the latest in pharmacology, health assessments, and quality assurance, as well as rapidly evolving technologies around healthcare technology and nursing informatics.

Similar to other CSU Global degree programs, students can choose degree specializations to align with their individual professional goals and personal interests. The MSN specializations include a Leadership and Administration and a Military and Veteran Healthcare option.

“As the healthcare profession continues to experience extraordinary demand, there is an increased need for trained and qualified nurse leaders,” said CSU Global Provost and Vice President of Strategic Development, Dr. Karen Ferguson. “We are proud to offer a customizable and flexible master’s degree in nursing that not only fits with the demanding schedules of current healthcare workers but also creates individual pathways to career success, such as through the unique and specialized military and veteran healthcare leadership track. ”

Enrollment for this new program is open now, with term starts offered each month. Interested students should contact Enrollment at 800-920-6723 or email enroll@csuglobal.edu to get started. For more information about CSU Global’s online Master of Science in Nursing, please visit CSUGlobal.edu/msn.

###

About Colorado State University Global

Colorado State University Global (CSU Global) offers career-relevant programs for modern learners. As the first and only 100% online, fully accredited public university in the United States, CSU Global is focused on student success as its number one priority. Embracing the land-grant heritage as part of the Colorado State University System, CSU Global sets the standard for quality and innovation in higher education through its expert faculty, who are recognized as industry leaders and trained in working with adults in an online learning environment. CSU Global offers accelerated eight-week courses that start every four weeks. Visit CSUGlobal.edu to learn more.

Share article on social media or email:

Avante Health Solutions Awarded Intalere Group Purchasing Agreement


Intalere, the healthcare industry leader in delivering solutions designed for improved financial, operational and clinical health for our partners, announces a new agreement for diagnostic imaging and ultrasound equipment from Avante Health Solutions.

Through this agreement Intalere members will receive negotiated pricing on refurbished medical imaging equipment (CT, MRI, cath/angio and ultrasound), on-site repair service, and a large inventory of replacement parts. In addition, Intalere members have access to Avante Health Solutions’ vast library of clinical training videos and technical support.

This contract is currently effective from October 1, 2020 through September 30, 2023.

About Avante Health Solutions

Avante Health Solutions is a single source provider of medical, surgical, diagnostic imaging, and radiation oncology equipment, including sales, service, repair, parts, refurbishing, and installation. Avante is making it easier and more affordable for every hospital, clinic, and medical practice to have the very best equipment, supplies and service. Visit https://avantehs.com to learn more.

About Intalere

Intalere’s mission focuses on elevating the health of healthcare by designing solutions to improve our members’ financial, operational and clinical performance. We empower our customers and deliver measurable results through our highly personalized approach of creating strategies and programs focused on their goals. From managing their entire spend to strategic consulting around diagnosing particular areas of concern, our unique provider led model allows us to leverage nationally recognized best practices in supply chain and patient outcomes to drive efficiencies for our members. To learn more, visit https://intalere.com.

Share article on social media or email:

FDAnews Announces — Pharmacy Compounding Regulation Webinar Oct. 14, 2020


WCG FDAnews

WCG FDAnews

Pharmacy Compounding Regulation:

FDA’s Latest Guidance, Compliance and Enforcement Activities

An FDAnews Webinar

Wednesday, Oct. 14, 2020, 1:30 p.m.-3:00 p.m. EDT

https://www.fdanews.com/pharmacycompounding

The Pharmacy Compounding Regulation webinar on Oct. 14, will help one form a better understanding of how the FDA and the Department of Justice are engaging in significant enforcement activity concerning compounders and outsourcing facilities, including issuing recalls, shutting down sterile operations and serving consent decrees.

The webinar will also consider the effect of the COVID pandemic on compounders and outsourcing facilities, FDA’s guidance on permitting certain drug products to be compounded and what effect, if any, this has had on this struggling industry and patient access.

DEA and FDA enforcement and litigation expert Karla Palmer will share critical current information around the FDA’s recent guidance and regulatory positions.

During this webinar, we’ll cover:

  • The significant differences between Sections 503A and 503B of the Food, Drug and Cosmetic Act (FDCA)
  • The FDA’s final memorandum of understanding (MOU) and updates to the bulk substances lists
  • The FDA’s position with respect to compounding pharmacies and outsourcing facilities considering drug shortages caused by the COVID-19 pandemic
  • The implications of recent enforcement actions the FDA has taken against compounders, including those against ABC Compounding in Georgia for inaccurate listing information for its antiseptic hand wash
  • The current focus of FDA inspections, including insanitary conditions
  • The important interplay between the FDA and states concerning the regulation of outsourcing facilities and compounding pharmacies
  • The recent case for Oxitriptan’s inclusion on the 503A list from the Summit Health Pharmacy in Georgia

The FDA is frequently releasing new guidance documents — shifting expectations and requirements constantly. Let our expert guide you through these changes.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Pharmacy Compounding Regulation:

FDA’s Latest Guidance, Compliance and Enforcement Activities

An FDAnews Webinar

Wednesday, Oct. 14, 2020, 1:30 p.m.-3:00 p.m. EDT

https://www.fdanews.com/pharmacycompounding

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/pharmacycompounding

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

Competitive Business Solutions (CBS) brings on former Healthcare CEO, Joseph W. Devine, to lead their Healthcare Practice


Joseph Devine Headshot

Joseph W. Devine, Healthcare Practice Lead, Competitive Business Solutions

“Healthcare is at a critical point, and I’m thrilled to work with executives and their organizations to define and support strategies needed to be successful in this new environment.” – Joseph Devine, Competitive Business Solutions, Healthcare Practice Lead

Joseph W. Devine, FACHE, former President & CEO of Kennedy Health System and Executive Vice President of Jefferson Health, joins Competitive Business Solutions (CBS), a New Jersey-based consulting firm, as their Healthcare Practice Lead.

A highly respected and active leader, Joe Devine became President & CEO of Kennedy Health in 2013, where he served as a senior-level executive for 30-plus years. Under Joe’s leadership, Kennedy Health was honored as one of the “Best Hospitals in the Country” by U.S. News & World Report for 2014-2015, and it was named a “Top Workplace” by Philly.com for five consecutive years, from 2014-2019.

Repeatedly recognized throughout his career, Joe received the “Senior-Level Healthcare Executive” Regent’s Award from the American College of Healthcare Executives (ACHE) in 2015 for his contributions toward the advancement of healthcare management excellence and the achievement of ACHE goals. Likewise, he was named to South Jersey Biz magazine’s “Power 50” list, which spotlights the region’s most influential business leaders, as well as to South Jersey Magazine’s “Who’s Who in Health Care” list. In both 2019 and 2020, Joe was also named to NJBIZ magazine’s “Power 100” list, featuring top leaders in New Jersey Health Care, as well as the “Power 50” list of New Jersey’s most impactful healthcare leaders.

Joe is the current Board Chair of the Southern New Jersey Chamber of Commerce and the former Board Chair of the New Jersey Hospital Association (2019), and he continues to serve on many advisory and community boards.

In 2018, Joe successfully negotiated and merged the Kennedy Health System with Thomas Jefferson University in Philadelphia, which resulted in Kennedy becoming part of one of the largest, most prestigious health systems in the country.

“I’m excited to work with CBS,” Joe affirms. “The CBS team has the vision, passion and experience to bring solutions to healthcare in way that is much more personal for organizations, based on my experience as a CEO.” Joe continues, “Healthcare is at a critical point, and I’m thrilled to work with executives and their organizations to define and support strategies needed to be successful in this new environment.”

“Joe’s gift is that he not only understands all aspects of healthcare, but he also maintains a passion for improving patient and family experiences through laser focus on workplace process improvements and leadership development,” says Ed Hoffman, President of CBS. “Joe’s background and experience will provide valuable insight and coaching to our clients while shaping our healthcare practice.”

Joe Devine holds a master’s degree in Business Administration from Philadelphia’s St. Joseph’s University. He is a Fellow in the American College of Healthcare Executives, having earned its highest level of recognition. The father of two grown daughters and three grandchildren, Joe and his wife, Dina, reside in Washington Township, NJ.

About CBS

CBS was founded over 20 years ago to provide proven, cost-effective solutions to organizations seeking to improve performance. CBS works with clients throughout the total product and service life cycle—from definition of need through strategy, planning and execution—turning teamwork, flexibility, visibility and speed into powerful tools to deliver the required results.

CBS prides itself on a core team of over 60 consultants who operate in more than 20 states. By engaging a highly experienced team, CBS has delivered hundreds of millions of dollars in annualized savings to its clients, along with significantly improved quality and processes. Through effective use of training, projects and events, CBS quickly gains buy-in at all levels of its clients’ operations. From there, savings and success naturally follow.

Share article on social media or email:

Meridian Clinical Research Wins Vaccine Industry Excellence (ViE) Awards for Best Clinical Trial Site and Best Clinical Trial Network in 2020


Meridian won the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site and Best Clinical Trial Network.

Meridian won the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site and Best Clinical Trial Network.

The winners were announced at the virtual World Vaccine Congress. The awards were decided by two rounds of voting and a scientific advisory board. Judges reviewed performance metrics, diversity of capabilities for vaccine trials, ongoing outcomes, and other factors to select a winner.

Meridian Clinical Research, a leading investigative research network, won the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is also the largest member of Platinum Research Network, which won the ViE award for Best Clinical Trial Network.

“It’s incredible to earn these awards when vaccine trials are the industry’s priority and so visible in the public spotlight,” said Nicole Osborn, Meridian founder and CEO. “It reaffirms the quality of work our investigators and staff put forward every day, and the trust we’ve established with leading vaccine developers.”

The winners were announced at the virtual World Vaccine Congress typically held in Washington. The awards were decided by two rounds of voting and a final judgement by a scientific advisory board. Judges reviewed performance metrics, diversity of capabilities for vaccine trials, ongoing outcomes, and other factors to select a winner.

“In the past few years, we focused on providing fast startup, immediate enrollment, and scalability for our clients’ vaccine research programs,” said Osborn. “When COVID-19 vaccine trials began, we had the capabilities and reach when Sponsors and CROs needed it most.”

Earlier this year, Meridian principal investigators were the first in the U.S. to enroll patients into Phase II and III COVID-19 vaccine studies. Leaders of the Operation Warp Speed (OWS) program — including Moncef Slaoui, chief advisor, and General Gustave F. Perna, chief operating officer — visited Meridian’s internal medicine site in Savannah, GA.

A longtime leader in vaccine research, Meridian is conducting COVID-19 vaccine clinical trials at nine of its 23 sites.

Sponsors and CROs interested in partnering with Meridian should email Andrew Kimball, VP, business development, at akimball@mcrmed.com.

***

About Meridian Clinical Research

Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is a multi-specialty site network headquartered at its dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials.

Share article on social media or email: